The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines

Intranasal vaccine administration can overcome the disadvantages of injectable vaccines and present greater efficiency for mass immunization. However, the development of intranasal vaccines is challenged by poor mucosal immunogenicity of antigens and the limited availability of mucosal adjuvants. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jieru, Boer, Jennifer C., Khongkow, Mattaka, Phunpee, Sarunya, Khalil, Zeinab G., Bashiri, Sahra, Deceneux, Cyril, Goodchild, Georgia, Hussein, Waleed M., Capon, Robert J., Ruktanonchai, Uracha, Plebanski, Magdalena, Toth, Istvan, Skwarczynski, Mariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961534/
https://www.ncbi.nlm.nih.gov/pubmed/36851183
http://dx.doi.org/10.3390/vaccines11020305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961534/
https://www.ncbi.nlm.nih.gov/pubmed/36851183
http://dx.doi.org/10.3390/vaccines11020305

Ejemplares similares